U K
B U S I N E S S
P A R K

home page






The information below comes from the UK Activity Report.
Click here for further details


Cambridge Biotechnology

Cambridge Biotechnology, the developer of obesity treatments with 29 staff, has been acquired by Biovitrum of Sweden for undisclosed terms. 23-Mar-2005

Cambridge Biotechnology has received £6m of venture capital to fund the development of new treatments for pain and obesity. 25-Jul-2002



The information above comes from the UK Activity Report








Copyright UK Business Park 1995-2007